Apart from increasing age and the apolipoprotein E (APOE) e4 allele, the causes of Alzheimer’s disease are largely unknown, and treatment trials have been disappointing.4 This has led to increasing interest in the potential for reducing Alzheimer’s by targeting modifiable risk factors. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.